To use all functions of this page, please activate cookies in your browser.
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
34 Current news about the topic ulcerative colitisrss
|You can refine your search further. Select from the filter options on the left to narrow down your results.|
AM-Pharma financing kick-starts Series C financing effort
AM-Pharma B.V., a biopharmaceutical company developing improved endogenous proteins to combat disease, announced the signing of a 2.5 million Euro financing agreement with its two main investors, Forbion Capital Partners and Inventages Venture Capital. The investment is a prelude to a Series C ...
Chi-Med, the Hutchison Whampoa backed pharmaceutical and healthcare Group, announced positive results for its Phase II proof-of-concept study for HMPL-004 in mild-to-moderate Ulcerative Colitis, a form of inflammatory bowel disease. The trial met its objective in that HMPL-004 was well tolerated ...
The US$ 7.6 bln market of TNF-antagonists attracts numerous follow-on compounds
The Business Intelligence firm La Merie S.L. reported that the huge market of US$ 7.6 bln in 2005 and the clinical validation of the target in many inflammatory indications has filled the pipeline of follow-on TNF-antagonists. Sales of the three marketed TNF antagonists etanercept, infliximab and ...
Genzyme Corp. and MacroGenics, Inc. announced that they have entered into a strategic partnership to develop novel therapies for immune-mediated diseases. Under the agreement, the companies will work together to advance MacroGenics' ongoing preclinical program targeting the Fc receptor CD16, an ...